The global development paradigm within the supply chain has made a tremendous impact that has changed the face of pharmaceutical distribution with the attendant disruptions. In order to be relevant in this era of uncertainty and disruptions, pharmaceutical wholesalers  and distributors need to define its relevance in the rapidly changing supply chain landscape. The most perceived strategy to overcome these challenges is by companies with common objective and interest to become more resilient, collaborative and networked with other stake holders and players in the chain.  Collectively they will be able to launch their entities/companies as vector of progress and change.  This necessitated the coming together of this group.